Ecraid begins its fight against infectious diseases
15 Feb, 2022
New foundation: The European Clinical Research Alliance for Infectious Diseases has begun Utrecht, Tuesday 15 February 2022 – In January 2022, Ecraid became a legal entity and is now fully…
Read More
Closer to micro-elimination of HCV in Russian adolescents and children
11 Feb, 2022
The REACH Consortium has just published the results of a multi-centre survey, aimed at assessing the uptake of Direct-acting antivirals (DAAs) for the treatment of HCV in children and adolescents…
Read More
Registration now open! PentaTr@ining 2022: HIV & other Congenital Infections
11 Feb, 2022
We are delighted to announce that registrations are now open for our interactive training course ‘PentaTr@ining 2022: HIV & other Congenital Infections‘. Building on the remarkable success of the previous…
Read More
Save the date! Penta aperitivo webinar 17 Feb 2022
10 Feb, 2022
The Penta Aperitivo webinars are here to keep you up to date with the latest Penta activities and on the new developments on the prevention, diagnosis, and treatment of infectious diseases in children. The next…
Read More
PediCAP microbiology sub-study sites receive training from LAB-NET
08 Feb, 2022
At the end of 2021, LAB-Net provided training on the sampling and microbiology procedures to all five sites taking part in the microbiology sub-study in the Paediatric Community Acquired Pneumonia…
Read More
Science4Pandemics: A European Gamification Project to Better Prepare Young People for Future Pandemics
27 Jan, 2022
The digital platform will educate young people and provide real-world data for collaborative research on pandemics. Barcelona, 27 January 2022. Despite the many advances in the global fight against…
Read More
COVID-19 vaccines for children, adolescents and immunocompromised patients
25 Jan, 2022
Penta is proud to be a partner in the Horizon Europe funded “RBD Dimer recombinant protein vaccine against SARSCoV2” (RBDCOV) project. Within the project we will be bringing our paediatric…
Read More
Once-daily DTG more effective in treating HIV in children
30 Dec, 2021
The ODYSSEY trial’s final paper Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children has been published in the New England Journal of Medicine. ODYSSEY, sponsored by Penta…
Read More
Ethical youth engagement in the HIV response
15 Dec, 2021
Penta youth in collaboration with IAS, have organised a webinar taking place on Thursday, 16 December at 12pm CET (GMT+1) on the theme Invest in our future: How to walk…
Read MoreREACH project published in CORDIS
07 Dec, 2021
We are proud to announce that the REACH project’s Result in Brief article, Reducing infectious disease in mothers and children in Russia, has been uploaded on the CORDIS website. This…
Read More
World AIDS Day 2021: How paediatric HIV has changed in the last 30 years
01 Dec, 2021
It takes a community of people working together to achieve the results we are looking for: eradication HIV in children The paediatric HIV pandemic has changed from when researchers…
Read More
NeoVanc: New study finds no clear benefit from a shorter optimised vancomycin treatment in babies with Gram positive late onset sepsis
27 Nov, 2021
The results of the study show that there is no clear advantage for adopting a shorter 5-day course, with a loading dose, over the standard 10-day course in infants under…
Read More
Public consultation on the draft WHO Essential Medicines List Antibiotic Book
25 Nov, 2021
Inputs collected during the public consultation will be considered in the revision and finalization of the publication and infographics
Read More
In Memory of Dr Scott M. Hammer
19 Nov, 2021
With a great sadness I learnt today that Scott passed away. The IAS obituary says everything about him as a great scientist. I just would like to remember him as…
Read More
World Pneumonia Day 2021: Every breath counts
12 Nov, 2021
It’s impossible to ignore the Covid-19 pandemic and how it has gripped the lives of everyone around the world, but it is equally impossible to ignore the thousands of lives…
Read More
ODYSSEY trial wins 2021 Hector Award
29 Oct, 2021
It was announced at the 8th European AIDS Conference that Angela Colbers and David Burger received the Hector Research Award in HIV 2021 in clinical and/or epidemiological science on behalf…
Read MoreDolutegravir-based ART is superior to NNRTI- and PI-based ART in infants, children and adolescents living with HIV (combined results of the main trial and the ‘under 14kg’ cohort)
28 Sep, 2021
Abstract ODYSSEY Internationalmulti-centre,randomised96-weeknon- inferiority trialWeaimedtocompareefficacyandsafetyofDTG-basedART with standard-of-care in children and adolescents starting first-line ART (ODYSSEY A) or second-line (ODYSSEY B) Main trial enrolled children≥14kg Aim to enrol ≥700 children: 310…
Read More
PentaTr@ining kicks off HIV and other Congenital Infections course, in Spanish
20 Sep, 2021
The Spanish language version of our online course “PentaTr@ining: HIV and other Congenital Infections” kicks off today! We look forward to welcoming over 100 participants for this year’s edition of…
Read More